Sees FY25 revenue $729M-$737M, consensus $727.5M
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RGEN:
- Repligen reports Q3 adjusted EPS 46c, consensus 42c
- Is RGEN a Buy, Before Earnings?
- Novo Nordisk update raises questions on Repligen approval, says Canaccord
- Repligen price target raised to $160 from $150 at Barclays
- Repligen’s Growth Potential: A Buy Rating Backed by Innovation and Strategic Positioning